Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Bausch Lomb Ord Shs T.BLCO

Alternate Symbol(s):  BLCO

Bausch + Lomb Corporation is a Canada-based global eye health company. The Company’s Vision Care segment includes both a contact lens business and a consumer eye care business that consists of contact lens care products, over the counter (OTC) eye drops and eye vitamins. The Company’s Ophthalmic Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (TSX:BLCO)

No current opinion is available.

Bullboard Posts (TSX:BLCO)

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Re

NEWS: $BLCO Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 GuidanceFourth-Quarter 2023 Financial...
whytestocks - February 21, 2024

Bausch + Lomb Will Acquire XIIDRA®

June 30, 2023 08:00 AM Eastern Daylight Time VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a...
Betteryear2 - June 30, 2023